MAIN LINE Oncology Hematology Associates Lankenau Cancer Center 100 E Lancaster Avenue Wynnewood, Pa 19096 610-645-2494 Lawrence Park 1991 Sproul Road Suite 100 Broomall, Pa 19008 610-645-2494 Medical Doctors Zonera Ali, MD Medical Oncologist, Hematologist, Main Line Oncology Hematology Associates Medical School: King Edward Medical School Pakistan Residency: Mount Sinai School of Medicine, NY Fellowship: Oncology/Hematology, Lankenau Hospital Board Certification: Medical Oncology, Hematology, Internal Medicine As a medical oncologist/hematologist, Dr. All treats the spectrum of adult cancer patients, from solid tumors to hematologic malignancies. She has contributed to scholarly articles on the motivations, concerns and perceptions of women considering genetic testing for breast cancer as well as on barriers to referral. Dr. Ali is one of the principal investigators in clinical trials which are offered through the Main Line Health Community Clinical Oncology Program (CCOP); she was director of the cancer genetics and risk assessment program from 2002-2006. Dr. Ali has led the industry's sponsored clinical trials for lung cancer. She has been in the forefront in prescribing cutting edge treatment to those patients through conventional and investigative treatments. Dr. Ali is hoard certified in medical oncology, hematology, and internal medicine and is a member of the American College of Physicians, American Medical Association, and the American Society of Clinical Oncology. Paul B. Gilman, MD Medical Director, Lankenau Hospital Cancer Center, Main Line Oncology Hematology Associates Chief of the Division of Hematology/Oncology at Lankenau Hospital and Section Chief of Medical Oncology for Main Line Health Medical School: Jefferson Medical College, Philadelphia, PA Residency: New England Deaconess Hospital, Boston, MA Fellowship: Thomas Jefferson University Hospital, Philadelphia, PA Board Certification: Medical Oncology, Hematology, Internal Medicine Dr. Gilman serves as the Principal Investigator (PI) for the Community Clinical Oncology Program (CCOP), which is 1 of 50 such National Cancer Institute (NCI) funded programs in the nation. In addition to serving as PI for several clinical trials of new therapeutic agents for cancer, Dr. Oilman has contributed to numerous peer-reviewed medical journals and is founding director of the Main Line Health Cancer Risk Assessment and Genetics Program. Dr. Gilman has served on the faculty of Medicine at Jefferson Medical College since 1983. He is also chairman of the Lankenau Oncology Strategic Planning Committee and of the Breast Cancer Treatment Committee. Dr. Gilman is a member of the American Society of Clinical Oncology and the American Society of Hematology. Clifford H. Pemberton, MD Medical Oncologist, Hematologist, Main Line Oncology Hematology Associates Medical School: Jefferson Medical College, Philadelphia, PA Residency: Lankenau Hospital, Wynnewood, PA Fellowship: Lankenau Hospital, Wynnewood, PA Board Certification: Medical Hematology, Internal Medicine, Hospice and Palliative Medicine In addition to patient care, Dr. Pemberton is active in several important roles within the health system. He is Medical Director of the Jefferson Hospice and Palliative Care Program and an Instructor in Medicine at the Jefferson Medical Col-lege. He has previously served as Program Director for the Lankenau Internal Medicine Residency Program. Dr. Pernberton's presentations within the medical community cover advanced concepts in oncologic-hematologic malignancies. He serves as a Registered Investigator for the Eastern Cooperative Oncology Group and is a member of the American Medical Association, the American Society of Hematology, the American Academy of Hospice and Palliative Medicine as well as the International Myeloma Foundation and several others. Erik L. Zeger, MD Medical Oncologist, Hematologist, Main Line Oncology Hematology Associates Medical School: MCP/Hahnemann University School of Medicine, Philadelphia, PA Residency: University of North Carolina at Chapel Hill Fellowship: University of North Carolina at Chapel Hill Board Certification: Medical Oncology, Hematology, Internal Medicine Dr. Zeger treats patients with all types of malignancy and hematological disorders. His interests include the management of gastrointestinal cancers, especially colorectal cancer, as well as the hematological cancers including multiple myeloma, leukemia and lymphoma. Dr. Zeger is an investigator with the Main Line Health Community Clinical Oncology Program (CCOP) at Lankenau including clinical trials assessing fatigue, symptom management and quality of life issues in cancer patients. Dr. Zeger serves on Lankenau's Quality and Safety Committee as well as the Hematology Curriculum advisor for the Internal Medicine Residency program. He is board certified in medical oncology, hematology, and internal medicine and is a member of the American Society of Clinical Oncology and American Society of Hematology. Nurses Lisa Rios, RN, BSN, OCN Donna Rook, RN, OCN Colleen Jackson, RN Created and Hosted by Chester County Sites Main Line Oncology Hematology Associates